POLYNUCLEOTIDE AND USE THEREOF
    1.
    发明申请
    POLYNUCLEOTIDE AND USE THEREOF 有权
    多核苷酸及其用途

    公开(公告)号:US20140141418A1

    公开(公告)日:2014-05-22

    申请号:US13899223

    申请日:2013-05-21

    Abstract: Provided is a dual-hybridization polynucleotide including a first complementary region that is complementary to the 3′-terminus of a target nucleic and a second complementary region that is complementary to the 5′-terminus of the target nucleic acid, a composition and kit including the polynucleotide, and a method of producing a nucleotide sequence complementary to the target nucleic acid. The first complementary region to be bound at the 3′-terminus of the target nucleic acid can be shortened and the target nucleic acid may be amplified with excellent specificity and/or sensitivity.

    Abstract translation: 提供了双杂交多核苷酸,其包含与靶核酸的3'末端互补的第一互补区和与靶核酸的5'末端互补的第2互补区,包含 多核苷酸,以及产生与靶核酸互补的核苷酸序列的方法。 可以缩短在靶核酸的3'-末端结合的第一个互补区,并且以优异的特异性和/或灵敏度扩增靶核酸。

    COMPOSITION AND KIT FOR DIAGNOSING BREAST CANCER INCLUDING POLYNUCLEOTIDE WITHIN VESICLE, AND METHOD OF DIAGNOSING BREAST CANCER USING THE SAME
    2.
    发明申请
    COMPOSITION AND KIT FOR DIAGNOSING BREAST CANCER INCLUDING POLYNUCLEOTIDE WITHIN VESICLE, AND METHOD OF DIAGNOSING BREAST CANCER USING THE SAME 有权
    用于诊断包括在囊内的多核苷酸的乳腺癌的组合物和试剂盒,以及使用该方法诊断乳腺癌的方法

    公开(公告)号:US20140178885A1

    公开(公告)日:2014-06-26

    申请号:US14132964

    申请日:2013-12-18

    CPC classification number: C12Q1/6886 C12Q2600/158 C12Q2600/178

    Abstract: A breast cancer diagnostic composition and kit, and methods of diagnosing breast cancer or acquiring information for breast cancer diagnosis by using the composition or kit are provided. The composition or kit includes a polynucleotide that is the same as or complementary to at least one microRNA (miRNA) selected from the group consisting of hsa-miR-126, hsa-miR-23a, hsa-miR-24, hsa-miR-19b, hsa-miR-103, hsa-miR-142-3p, hsa-miR-144, hsa-miR-15a, hsa-miR-185, hsa-miR-93, and hsa-miR-30c in a vesicle, or a fragment of the microRNA.

    Abstract translation: 提供乳腺癌诊断组合物和试剂盒,以及通过使用该组合物或试剂盒诊断乳腺癌或获取乳腺癌诊断信息的方法。 该组合物或试剂盒包括与选自hsa-miR-126,hsa-miR-23a,hsa-miR-24,hsa-miR- 19b,hsa-miR-103,hsa-miR-142-3p,hsa-miR-144,hsa-miR-15a,hsa-miR-185,hsa-miR-93和hsa-miR-30c, 或微小RNA的片段。

Patent Agency Ranking